Lesão central de células gigantes agressiva: relato de caso e revisão dos aspectos atuais
Aggressive central giant cell granuloma: a case report and review of the current aspects
Matos, Felipe Rodrigues de; Benevenuto, Thais Gomes; Medeiros, Ana Míriam Costa de; Silveira, Éricka Janine Dantas da; Freitas, Roseana Almeida
Rev. odontol. UNESP, vol.38, n5, p.324-327, 2009
Abstract
A lesão central de células gigantes (LCCG) é considerada uma lesão rara de natureza proliferativa, de etiologia e patogenia desconhecidas. Ocorre mais em região de mandíbula e no gênero feminino. Este artigo relata um caso de LCCG em uma paciente do gênero feminino, 30 anos, melanoderma, e aborda aspectos atuais desta lesão, no tocante ao comportamento clínico, etiopatogenia e tratamento.
Keywords
Lesão de células gigantes, mandíbula, central
Resumo
The central giant cell granuloma (CGCG) is regarded as a rare proliferative lesion of unknown etiology and pathogenesis. It occurs frequently in the jaw region and in females. This article reports a case of CGCG in a female patient, 30 years-old, black and addresses current aspects of this lesion with regard to clinical behavior, pathogenesis and treatment.
Palavras-chave
Central giant cell granuloma, mandible, central
References
1. Lange J, Hans AVDP, Henk BVDH. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:603-15.
2. Ünal M, Karabacak T, Vayisoglu Y, Bagis HE, Pata YS, Akbas Y. Central giant cell reparative granuloma of the mandible caused by a molar tooth extaction: Special reference to the manuever of drilling the surgical field. Int J Pediatr Otorhinolaryngol. 2006;70:745-8.
3. Vered M, Shohat I, Buchner A, Dayan D, Taicher S. Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:226-39.
4. Cossío PI, de Fuentes RM, Carranza AC, Lagares DT, Pérez JLG. Recurrent central giant cell granuloma in the mandible: Surgical treatment and dental implant restoration. Med Oral Patol Oral Cir Bucal. 2007;12:E229-E232.
5. Souza PEA, Mesquita RA, Gomez RS. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions. Oral Dis. 2000;6:35-9.
6. Sholapurkar AA, Pai KM, Ahsan A. Central giant cell granuloma of the anterior maxilla. Ind J Dent Res. 2008;19(1):78-82.
7. Bataineb AB, Al-Khateeb T, Rawashdeb MA. The surgical treatment of central giant cell granuloma of the mandible. J Oral Maxillofac Surg. 2002;60:756-61.
8. Souza PEA, Paim JFO, Carvalhais JN, Gomez RS. Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor. J Oral Pathol Med. 1999;28:54-8.
9. Buresh CJ, Seemayer TA, Nelson M, Neff JR, Dorfman HD, Bridge J. t(X; 4) (q22; q131. 3) in giant cell reparative granuloma. Cancer Genet Cytogenet. 1999;115:80-1.
10. Aragão MS, Piva MR, Nonaka CFW, Freitas RA, Souza LB, Pinto LP. Central giant cell granuloma of the jaws and giant cell tumor of long bones – an immunohistochemical comparative study. J Appl Oral Sci. 2007;15:310-6.
11. Dewar AL, Farrugia AN, Condina MR, Bik TL, Hughes TP, Vernon-Roberts B, et al. Imatinib as a potential antiresorptive therapy for bone disease. Blood. 2006;107:4334-7.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email